High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer-Reference-Cited by-同舟云学术

High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer

Published:2019-12-21 Issue:4 Volume:9 Page:1321-1327
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Ito Masaaki¹,Yajima Satoshi²,Suzuki Takashi²,Oshima Yoko²,Nanami Tatsuki²,Sumazaki Makoto²,Shiratori Fumiaki²,Funahashi Kimihiko²,Tochigi Naobumi³,Shimada Hideaki¹²^ORCID

Affiliation:

1. Department of Clinical Oncology Toho University Graduate School of Medicine Tokyo Japan

2. Department of Gastroenterological Surgery Toho University School of Medicine Tokyo Japan

3. Department of Surgical Pathology Toho University School of Medicine Tokyo Japan

Funder

Japan Agency for Medical Research and Development

School of Medicine

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2789

Reference29 articles.

1. p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma

2. Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1

3. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

4. Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial

5. Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related Diseases;International Journal of Molecular Sciences;2024-04-30

2. Fabrication of electrochemiluminescence aptasensor for PD-L1 detection based on luminescent CdS@Ce-MOF@Au;Microchemical Journal;2023-10

3. Meta-analysis of the prognostic value of soluble programmed death ligand-1 (sPD-L1) in cancers;Biomarkers;2023-07-02

4. The Immune Checkpoint Receptor CD96: A Local and Systemic Immune Modulator in Oral Cancer?;Cancers;2023-04-02

5. Soluble PD-L1: a potential dynamic predictive biomarker for immunotherapy in patients with proficient mismatch repair colorectal cancer;Journal of Translational Medicine;2023-01-13